Related Experiment Videos
Lead screening in the general pediatric clinic
1University of Virginia School of Medicine, Charlottesville, USA.
Virginia Medical Quarterly : VMQ
|January 1, 1996
Summary
Pediatric lead screening at UVa found lower prevalence than other studies. Clinic staff recommend targeted screening based on risk factors, like housing age, to manage costs.
Area of Science:
- Pediatric Environmental Health
- Public Health
- Toxicology
Background:
- Elevated blood lead levels pose significant health risks to children.
- Previous studies have established varying prevalence rates of childhood lead exposure across different regions.
- Understanding local prevalence is crucial for effective screening strategies.
Purpose of the Study:
- To determine the prevalence of elevated blood lead levels in the University of Virginia (UVa) pediatric clinic population.
- To compare UVa's prevalence rates with national and regional data.
- To inform recommendations for lead screening protocols in pediatric settings.
Main Methods:
- Analysis of blood lead levels in children attending the UVa pediatric clinic.
- Comparison of prevalence data with findings from Bronson and Renier, Pirkle and colleagues (NHANES III), Norman and associates, and the city of Denver.
- Evaluation of screening costs and risk assessment factors.
Main Results:
- UVa pediatric population showed a 5.7% prevalence of lead levels ≥ 10 µg/dL and 1.1% ≥ 15 µg/dL.
- These rates were lower than those reported in Duluth, NHANES III, and North Carolina studies.
- No children screened had lead levels ≥ 25 µg/dL or ≥ 45 µg/dL.
Conclusions:
- The prevalence of elevated lead levels at the UVa pediatric clinic is relatively low compared to other reported populations.
- Given the cost of universal screening and lower local prevalence, targeted screening is favored.
- Screening based on specific risk factors, particularly living in older housing (pre-1960), is recommended.